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Invited Commentary

Update on RFA Increasing Use of Cardiac and Pulmonary
Rehabilitation in Traditional and Community Settings
NIH-Funded Trials
ADDRESSING CLINICAL TRIAL CHALLENGES PRESENTED BY THE COVID-19
PANDEMIC
Susan T. Shero, BSN, MS; Roberto Benzo, MD, MS; Lawton S. Cooper, MD, MPH;
Joseph Finkelstein, MD, PhD; Daniel E. Forman, MD; Diann E. Gaalema, PhD; Lyndon Joseph, PhD;
Steven J. Keteyian, PhD; Pamela N. Peterson, MD, MSPH; Antonello Punturieri, MD, PhD;
Susan Zieman, MD, PhD; Jerome L. Fleg, MD

W

e previously reported on an initiative to increase the
uptake of cardiac rehabilitation (CR) and pulmonary
rehabilitation (PR) in traditional and community settings
funded by the National Heart, Lung, and Blood Institute
(and the National Institute on Aging [NIA]).1 The overall
objectives of the initiative and those reflected in the funded
research projects are to (1) test strategies that will lead to
increased use of CR and PR in the US population who are
eligible based on current clinical guidelines; (2) test strategies
to reduce disparities in the use of CR and PR based on age,
gender, race/ethnicity, and socioeconomic status; and (3) test
whether increased use of CR and PR, whether administered
by traditional center-based or new models, is accompanied
by improvements in relevant clinical and patient-centered
outcomes. The NIA funding opportunity announcement addressed one or more specific age-related factors.
At the time of our previous report, the six funded projects (four CR and two PR) had successfully met milestones
for the initial grant year and had transitioned into the second year, most having begun participant recruitment. At
the initial investigator meeting in October 2019, principal
investigators from all six trials presented their progress and
exchanged valuable feedback. Summaries of the respective
research projects published in 2020 highlight the features
of the research studies.1 The October 2020 investigator
meeting focused on the effects of the novel coronavirus
(COVID-19) pandemic on the projects, trial adaptations
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to address related challenges, lessons learned, and potential
paths forward.
On March 11, 2020, the World Health Organization declared the COVID-19 outbreak a global pandemic.2 Most
hospitals and clinics suspended nonemergent procedures,
surgical procedures, and appointments, including center-based CR and PR sessions. Other overarching factors
affected the conduct and progression of clinical research,
including fear of contracting COVID-19 among potential
study participants and researchers, stay-at-home orders issued by local governments, and the need for clinician researchers to shift their responsibilities solely to the inpatient
clinical setting, notably pulmonary and critical care medicine. In most areas of the US, the temporary suspension of
in-person clinical services was in place from March to May
2020, with gradual partial reopenings beginning in May.3
At the onset of the pandemic, the National Institutes of
Health issued guidance outlining flexibilities for studies impacted by the COVID-19 public health emergency. Grant
recipients were encouraged to consult with their institutional review boards and institutions about potential measures
to protect participants and research staff. Concurrently, the
Centers for Medicare & Medicaid Services expanded access
to telehealth visits for Medicare beneficiaries and to many
behavioral health and education services delivered via telehealth and audio-only communications.3,4
For this CR/PR initiative, the COVID-19-related shutdowns and suspension of services required the study teams
to quickly submit revised protocols to ensure the safety
of participants and research staff. Sites modified interventions, assessments, and data collection to minimize direct
participant contact (Table). Psotka and colleagues5 discuss
these types of changes in end point collection, functional and exercise measures, and statistical analysis in expert consensus recommendations for clinical trials in the
COVID-19 age. The specific approaches taken to address
the COVID-19-related challenges for each funded trial are
summarized next.

PROJECT UPDATES
Project Title: Improving ATTENDance to Cardiac Rehabilitation (iATTEND). Principal Investigator: Steven J. Keteyian, PhD, Henry Ford Hospital, Detroit, MI (HL 143099).
The primary aim of the iATTEND trial is to assess the
efficacy of hybrid CR (HYCR) on attendance. The primary hypothesis is that patients randomized to HYCR will
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Table
COVID-19-Related Study Changes in This CR/PR Collaborative Initiative

CR/PR Project

Primary End Point(s)

Secondary
End Point(s)

Statistical
Analysis Plan

Recruitment Status
at Time of Suspension
of Services

Included data from the
26 patients affected
by trial suspension

For primary end
point, DSMB
considering
how to include
data from the
26 participants
impacted
by trial
suspension

Protocol

Other

78 patients enrolled,
with 26 participants
actively participating
in CR randomized
before suspension.
No recruitment midMarch to mid-May.
Enrollment resumed
in June

Revised during
suspension.
In-person
sessions
temporarily
changed to
synchronized
telehealth
visits and
phone calls.

CR hybrid-program
telehealth model
enhanced from
a one-on-one
patient-to-staff
encounter to a
WebEx platform,
allowing for
simultaneous
virtual engagement
of three to five
patients during a
45-min period

No change
anticipated

65 participants
recruited and 15
still participating in
CR. No recruitment
between March 16,
2020, and June 7,
2020

In-person
interventions
changed
to remote
(phone,
e-mail, postal
mail)

Anticipate need for
4-mo extension

iATTEND

Number of sessions
attended,
percentage of
patients completing
36 visits (hybrid
vs traditional).
26 participants
affected by
suspension

HeLP

Attendance at CR.
Data collected for
remote sessions
during suspension

ERA Nudge

Participation in CR.
Will count logging
exercise into app
and phone calls as
participation during
suspension

Exercise capacity
originally assessed
by METs on
treadmill. Changed
to 6MWT

No change
anticipated

112 patients enrolled,
21 were active
in center-based
program and 10
active in homebased program
March to May.

Center-based CR Added messaging
changed to
for all patients
fully remote
regarding
March to May.
precautions for
Some outdoor
COVID-19. During
in-person
inclement weather,
sessions
limited use of
began in May.
gym for in-person
sessions.

MACRO

Changed from SPPB
that requires
direct supervision
to self-reported
AM-PAC-CAT Basic
Mobility Domain

Accelerometry
elevated into a more
prioritized end point
and integrated with
the AM-PAC-CAT
as a complementary
performance
measure

No change
anticipated

43 enrolled prior to
suspension. Stopped
by the DSMB on
March 16, 2020,
and resumed (with
protocol changes
approved by the IRB)
on September 21,
2020

Significantly
revised to
facilitate
remote
processes.
Changes
approved on
July 10, 2020.
Sample size
reduced from
480 to 374.

Overall shift from sitevs-home-based
CR to home- and
hybrid-based
models.

Increasing
Adherence
to PR After
COPD-Related
Hospitalizations

Percentage of patients
that initiate and
complete PR after
a COPD-related
hospitalization—
unchanged

Patient choice of homebased vs on-site
PR—unchanged

Original intent-totreat analyses
retained. Two
secondary
analyses
added.

Recruitment deferred
during suspension.
Sample size
increased to 240
(from 150) as it is
now noninferiority
study.

Revised to have
no contact
enrollment

The study transitioned
to allow the
individuals referred
to the PR center to
have the choice of
either on-site PR or
telehealth homebased PR program.

CHIEF-PR

Completion rate of PR
after acute COPD
exacerbation—
unchanged

To assess exercise
capacity at patient
homes, 6MWT replaced
by 1-min sit-to-stand
test. Surveys and
questionnaires collected
remotely using NIH
Toolbox for PROs.

No change
anticipated

Recruitment postponed
until mid-June; no
participants affected
by suspension.
Increased enrollment
rates after June—
currently on track

Revised to
Online Patient
Enrollment
Network

The study transitioned
to a remote
assessment of
exercise capacity
at patient homes.

Abbreviations: AM-PAC-CAT, Activity Measure for Post-Acute Care with Computerized Adaptive Testing; COPD, chronic obstructive pulmonary disease; CR, cardiac rehabilitation; DSMB,
Data and Safety Monitoring Board; IRB, institutional review board; MET, metabolic equivalent; NIH, National Institutes of Health; PR, pulmonary rehabilitation; PRO, patient-reported outcome;
6MWT, 6-min walk test; SPPB, Short Physical Performance Battery.

2    Journal of Cardiopulmonary Rehabilitation and Prevention 2021;00:1-5

www.jcrpjournal.com

Copyright © 2021 Wolters Kluwer Health, Inc. Unauthorized reproduction of this article is prohibited.

complete significantly more CR sessions than patients randomized to clinic-based CR alone. Secondary aims are to
assess the effect of HYCR on exercise capacity and quality
of life. In mid-March 2020, all outpatient clinical and research activities were suspended at Henry Ford Hospital.
This policy impacted 26 patients actively engaged in either
the standard CR (S-CR) or hybrid CR (combined clinic- and home-based using video synchronized telehealth)
arms of the trial. Regardless of study group assignment, for
these 26 patients, the number of CR sessions attended at
the time CR operations were suspended was used as their
total number of sessions completed for the trial (Table). The
COVID-19-related suspension directly impacted assessment
of the primary trial end points, and the Data and Safety
Monitoring Board (DSMB) is evaluating how to include the
data from these 26 patients in the statistical analysis. For
example, one trial whose primary end point was impacted by COVID-19 excluded all affected participant-related
data from their primary analysis but included such data in
secondary analyses.6 In June 2020, new patient enrollment
resumed using COVID-19-specific procedures (eg, wearing
a mask during CR, individual vs group education).
Due to COVID-19, the findings from iATTEND take on
increasing importance because the trial evaluates the delivery of CR outside the facility-based setting.7 Additionally,
because of COVID-19, health systems are now better prepared to assist CR programs by adding telehealth-based
HYCR programs to their services. To leverage these system-level advances within Henry Ford Health System, in
February 2021, the CR hybrid program switched its telehealth model from a one-on-one patient-to-staff encounter8,9 to a WebEx platform (Cisco) that allows simultaneous and virtual engagement of three to five patients in a
real-time manner during a 45-min period, with the goal of
at least 30 min of supervised exercise for each person. The
autumn 2020 surge in COVID cases in Michigan did not
necessitate appreciable alterations in trial operations.
Project Title: Improving Participation in Cardiac Rehabilitation Among Lower-Socioeconomic Status Patients: Efficacy of Early Case Management and Financial Incentives.
The Healthy Lifestyle Program (HeLP) Study. Principal Investigator: Diann Gaalema, PhD, University of Vermont,
Burlington, VT (HL 143305).
The goal of the HeLP trial is to test the impact of two
interventions: case management and incentives on participation in CR among Medicaid enrollees of low socioeconomic status.1,10 On March 16, 2020, trial recruitment was
suspended, and the CR facility ceased normal operations
due to the COVID-19 outbreak. At this time point, the
study had recruited 65 participants, of whom 15 were still
participating in CR.
The CR program transitioned from in-person visits to
weekly telehealth phone calls for currently enrolled patients.
Accordingly, the study pivoted to encouraging remote attendance. To maintain a consistent target of encouraging
or incentivizing 2-3 visits/wk, at-home exercise sessions
were included. For each of these sessions, CR staff set a
patient-specific step goal, and objective measures of step
counts were obtained with pedometers (Omron).11,12 Study
interventions switched to completely remote delivery, with
case management conducted by phone and incentives delivered by email or mail, to encourage participation in weekly
telehealth visits and complete step goals. The trial continued to operate fully remotely for 8 wk before the CR program began a phased reopening in May. While COVID-19
surges have occurred in late 2020 to early 2021, infection
rates have remained low in Vermont, and the clinic has not
been required to reduce operations.

www.jcrpjournal.com

The main outcome for this trial is attendance at CR. As
the team was able to continue data collection and CR sessions remotely, investigators anticipate using data from this
time and do not foresee a need for changes to the statistical
plan. However, to account for the cessation of recruitment
for 11 wk due to research restrictions, they may need to
extend trial recruitment by 4 mo.
Project Title: Enhancing Cardiac Rehabilitation Adherence Through Home-Based Rehabilitation and Behavioral
Nudges (ERA Nudge). Principal Investigator: Pamela Peterson, MD, MSPH, Denver Health Medical Center, Denver, CO, and University of Colorado Anschutz Medical
Campus, Aurora, CO (HL 143324).
The goal of ERA Nudge is to increase adherence to and
completion of CR in a diverse, low socioeconomic status
population. The study is testing the choice of home versus hospital-based rehabilitation and behavioral nudge
messages.13,14 All patients receive an application (app) on
their smartphone that allows them to access information,
chat with staff, and receive educational information.15,16
On March 13, 2020, all in-person research activities were
suspended due to COVID-19, and the in-person clinical CR
program was closed. At that time, 112 patients had been
enrolled, 21 were active in the center-based program, and
10 were active in the home-based program.
In response to this situation, the team moved to a fully remote program, with patients who were enrolled in
center-based CR receiving phone calls on the days of their
previously scheduled classes. Participants received teaching and exercise coaching. Those who were enrolled in the
home-based program continued to receive one phone call/
wk as per the protocol. The collection of survey data was
by phone, and assessment of exercise capacity was delayed.
The team continued to deliver nudge messaging with added messages for all participants regarding precautions for
COVID-19. For example, the messages encouraged them to
use mail pharmacies, prescription delivery, or have friends
or family members pick up medication refills to avoid exposure to COVID-19. Recruitment was suspended for approximately 6 wk. In early May, the investigators were able
to reopen center-based classes and resume enrollment, with
approval from the hospital to hold classes in the park next
to the hospital, with an option for indoor sessions with
two to three participants/class on inclement weather days.
This outdoor model was developed based on experience in
Toronto.17
The primary outcome of the trial remains CR participation. When no in-person visits were allowed, participation
was counted as logging exercise into the app and participating in phone calls. No changes are anticipated in the statistical analysis. Exercise capacity is a secondary outcome,
which was originally assessed as metabolic equivalents
(METs) on the treadmill but switched to 6-min walk test
(6MWT) due to COVID-19 (Table).
Project Title: Modified Application of Cardiac Rehabilitation for Older Adults (MACRO). Principal Investigator:
Daniel E. Forman, MD, University of Pittsburgh, Pittsburgh, PA (AG 060499).
Modified Application of Cardiac Rehabilitation for Older Adults (MACRO) is a randomized controlled multisite
trial in which precepts of cardiology and geriatrics are
merged. A coaching intervention is employed by MACRO
that aims to increase function in older adults hospitalized
with cardiac disease by increasing their participation in
CR. The MACRO coaches use behavioral prompts to better motivate patient interests in CR programs and facilitate
options for site-based, home-based, and hybrid (site-based
transitioning to home-based) formats of CR to best match
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circumstances and preferences for each patient. The preCOVID-19 MACRO protocol relied heavily on face-to-face
assessments. The pre-COVID-19 primary end point was the
Short Physical Performance Battery,18 a performance measure of gait, balance, and strength that requires direct supervision to maintain safety and fidelity.
When the COVID-19 pandemic was declared, the trial
was suspended by the DSMB, as the direct engagements
required by the protocol were no longer feasible. The 43
pre-COVID-19 enrollees were released from the trial and
their data removed from the analysis. The study team had
to extensively revise the protocol to achieve practical, sensitive, and safe methods without face-to-face encounters. The
primary end point was changed to the Activity Measure for
Post-Acute Care with Computerized Adaptive Testing Basic Mobility Domain,19 a self-reported measure of physical
function that can be administered by phone. The sample
size was reduced from 480 to 374.
In addition to the Activity Measure for Post-Acute Care
with Computerized Adaptive Testing, remotely facilitated
accelerometry was prioritized as a complementary performance measure.20 Despite these significant changes, great
efforts were made to preserve the original primary goal (ie,
improving functional capacity by facilitating CR).
The MACRO study was initially designed to study tradeoffs between site-based and home-based CR. However, as
a pragmatic trial, it has shifted focus since the pandemic
to home-based and hybrid CR models because these have
become more common options of care. As a pragmatic trial, MACRO will be able to track the utility of these novel
approaches to CR, which may better serve older, complex,
and/or frail patients who could not easily attend site-based
programs even before COVID was a concern.
Project Title: Increasing Adherence to Pulmonary Rehabilitation After COPD-Related Hospitalizations. Principal
Investigator: Roberto Benzo MD, MS, Mayo Clinic, Rochester, MN (HL 142933).
The goal of this clinical trial is to compare adherence
to PR after referral to either a centralized home-based PR
program21 or a center-based program that offers on-site
PR after a chronic obstructive pulmonary disease (COPD)related hospitalization. Centralized home-based PR involves
delivery of all home PR program materials virtually and/or
remotely. The center can take referrals from any provider,
and provide home PR to any patient in the country, facilitating use by small hospitals, rural hospitals, or hospitals
with low resources to deliver home PR. The randomized
trial was slated to start in March 2020, but was delayed
because of the COVID-19 pandemic.
In response to the COVID-19 public health emergency, the Centers for Medicare and Medicaid Services added PR services to the Medicare telehealth reimbursement
list. Due to this change, PR centers can now offer telehealth
PR. Thus, the study transitioned to allow the individuals
referred to the PR center to choose either on-site PR or the
telehealth home-based PR program. The changes made in
the context of a public health emergency will provide the
study with generalizable and practical results while respecting the original goals as funded:
1. The investigators will still learn the percentage of
patients who initiate and complete PR after a COPD-related hospitalization to compare to the current dismal
<2% PR initiation in the same setting22 found in a
large study of Medicare beneficiaries.
2. The team will learn about patient choice of home-based
versus on-site PR after a COPD hospitalization.

The primary outcome of this study, completion of the
3-mo PR program, will continue to be based on intention-to-treat analysis, wherein comparisons will be made
between the two randomization groups: referral to centralized home-based PR versus referral to a PR center. Because
of the COVID-19-related changes, two secondary analyses
also will be performed: a per-protocol analysis combining
participants in the centralized home-based PR arm with
those in the PR center arm that chose home-based telehealth
versus hospital-based PR, and an analysis comparing three
participant arms: those randomized to home-based PR,
those randomized to hospital PR who chose home-based
telehealth PR, and those randomized to hospital PR who
chose on-site PR. The sample size will increase from 150 to
240 patients, and the design will change to a noninferiority
study.
Project Title: Comprehensive Health Informatics Engagement Framework for Pulmonary Rehabilitation (CHIEFPR). Principal Investigator: Joseph Finkelstein, MD, PhD,
Icahn School of Medicine at Mount Sinai, New York, NY
(HL 143317).
The Comprehensive Health Informatics Engagement
Framework for Pulmonary Rehabilitation (CHIEF-PR)
aims to facilitate PR referrals, initial assessments, completion rates, and maintenance using an innovative multipronged approach. The goal of this trial is to demonstrate
that the CHIEF-PR is effective in increasing the use of PR in
patients after an acute exacerbation of COPD, and improving clinical and patient-reported outcomes as compared
with routine clinical care. The CHIEF-PR is a multipronged
integrated trial, which addresses barriers for PR uptake and
completion using integrated multilevel information technology solutions at the health care, provider, and patient
levels. Recruitment into the clinical trial was supposed to
commence in March 2020 but was postponed until midJune due to the COVID-19 pandemic. Thus, the study participants were not affected by the clinical trial shutdown.
During the trial shutdown, the investigators refined
their enrollment and follow-up procedures to ensure sufficient social distancing and participant protection from
COVID-19 risks. Initial patient contact is now carried out
by hospital staff providing interested patients with access to
an electronic consenting platform via their smartphone or
tablet.23 The entire study is conducted at participant homes
after discharge from a hospital. An individualized exercise
program is prescribed after remote assessment of exercise
capacity using a validated telehealth system.24 To assess exercise capacity at participant homes, the team replaced the
6MWT with a 1-min sit-to-stand test, which was previously
demonstrated to be a reliable alternative to the 6MWT.25
As originally planned, participants in the intervention
group follow their exercise plan daily using a home-based
telerehabilitation system. In comparison, those in the control group receive only printed materials provided after the
initial assessment. Physical activity assessment was planned
using Fitbit devices. However, the team found that Fitbit
accuracy depended on pace and sensor location,26 which
may bias estimates in older adults. Additionally, the number of steps may be affected by social isolation during a
lockdown. These considerations resulted in using the Physical Functioning Scale of the Short-Form 36, whose internal
consistency and validity in older adults have been well established27 (Table).
The sample size and primary outcome of the CHIEF-PR
trial, and the completion rate of PR after acute COPD exacerbation, have not changed. The team has increased patient enrollment rates to address the initial delay in the trial
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commencement, and the current CHIEF-PR accrual to date
has reached initially planned milestones.

SUMMARY AND FUTURE DIRECTIONS
The overall objectives of this CR/PR initiative include using
new models to increase the uptake of CR/PR in both traditional and community settings. Thus, several of the research
projects already employed virtual and/or remote components
as part of their original protocols before the COVID-19
pandemic. With the onset of this public health emergency,
a rapid shift to new and more extensive uses of telehealth,
remote monitoring and assessment, and virtual oversight/
supervision approaches were initiated to ensure patient and
research staff safety and maintain study integrity to the extent possible (Table). Central to the investigator ability to
address trial shutdown challenges was ongoing supportive
guidance by the National Institutes of Health staff.
The research questions addressed by these projects have
become more critical in light of the pandemic. It is crucial to
understand whether safe, effective, and efficient CR/PR programs can be delivered remotely and/or virtually in homebased and hybrid settings. In a post-COVID world, hospitals
and clinics may add or enhance remote and/or virtual components to their CR/PR programs to establish safe, effective
hybrid programs. Overall, the research projects underwent
numerous adaptations and revisions to address the considerable challenges posed by COVID-19. Despite these challenges,
the trials may provide even more valuable, generalizable, and
practical results in a post-COVID-19 world in which innovative approaches are likely to remain at the forefront of CR/
PR delivery. Study adaptations, including early contingency
planning and risk management protocols, are needed for the
future to address potential public health emergencies, natural
disasters, travel or communication disruptions, policy changes, and social and demographic factors in target populations.
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